AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitabetic M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitabetic M 50mg/500mg Tablet

Diabetic Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent severe diabetic complications like kidney disease and vision loss, potentially lowering heart attack and stroke risk. Diabetic Duo 50mg/500mg may be used independently or with other diabetes treatments. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and other medications. Consuming it with meals minimizes stomach upset. Consistent daily intake at the same time maximizes effectiveness; discontinuation should only occur under medical supervision. Maintaining your prescribed diet and exercise regimen is crucial for diabetes control; lifestyle significantly impacts management. Common side effects include nausea, vomiting, diarrhea, stomach discomfort, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential risk, especially when combined with insulin or sulfonylureas; learn to recognize and manage this. This medication isn't for everyone. Inform your physician of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before starting. Pregnant or nursing individuals should seek medical advice prior to use. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be limited due to its blood glucose-lowering effects. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Uses of Sitabetic M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitabetic M 50mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Sitabetic M 50mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Sitabetic M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitabetic M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Sitabetic M 50mg/500mg tablets should be administered with a meal.

How Sitabetic M 50mg/500mg Tablet works:

Sitabetic M 50mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Sitabetic M 50mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitabetic M 50mg/500mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitabetic M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitabetic M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Sitabetic M 50mg/500mg tablets are contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of Sitabetic M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitabetic M 50mg/500mg Tablet :

Should you forget a dose of Sitabetic M 50mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitabetic M 50mg/500mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Medication for diabetes

FAQs on Sitabetic M 50mg/500mg Tablet

Sitabetic M 50mg/500mg tablets contain sitagliptin and metformin, treating type 2 diabetes mellitus in adults. This medication enhances blood sugar control when combined with a healthy diet and regular physical activity. Metformin reduces liver glucose production and improves insulin responsiveness. Sitagliptin blocks DPP-4, boosting insulin secretion from the pancreas. This formulation is unsuitable for individuals under 18.
Prolonged Sitabetic M 50mg/500mg Tablet use can indeed lead to vitamin B12 deficiency by hindering its gastrointestinal absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, as proposed by some studies, include annual supplemental vitamin B12 intake.
Taking Sitabetic M 50mg/500mg tablets may result in frequent side effects such as low blood sugar, taste changes, queasiness, abdominal discomfort, loose stools, headaches, and upper respiratory illnesses. Rare but potentially severe adverse reactions include lactic acidosis. Prolonged use might also cause vitamin B12 deficiency.
Patients with hypersensitivity to any Sitabetic M 50mg/500mg Tablet constituent or inactive ingredient should not use this medication. Its administration is contraindicated in individuals with severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabetic M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store the medication in its original, tightly sealed container or packaging, following the storage instructions provided. Discard any leftover medication. Prevent access by children, pets, and other individuals.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential complication of Sitabetic M 50mg/500mg Tablet. Also termed Metformin-associated lactic acidosis (MALA), this rare adverse effect necessitates caution in patients with renal impairment, the elderly, or those with high alcohol consumption. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia warrant immediate discontinuation of Sitagliptin + Metformin and prompt medical attention.
Sitabetic M 50mg/500mg tablets contain sitagliptin and metformin, working synergistically to manage type 2 diabetes in adults. This medication helps regulate blood sugar when combined with a healthy diet and physical activity. Metformin reduces hepatic glucose production and enhances insulin responsiveness, while sitagliptin blocks DPP-4, promoting increased pancreatic insulin secretion. This formulation is unsuitable for individuals under 18.
Sitabetic M 50mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Individuals with hypersensitivity to any constituent or inactive ingredient within Sitabetic M 50mg/500mg Tablet should refrain from its use. This medication is contraindicated in patients exhibiting severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabetic M 50mg/500mg tablets with alcohol is unsafe due to an elevated risk of lactic acidosis.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential side effect of Sitabetic M 50mg/500mg Tablet. Also termed Metformin-associated lactic acidosis (MALA), this rare complication necessitates caution in patients with pre-existing kidney impairment, the elderly, or those consuming significant alcohol. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal discomfort, and bradycardia warrant immediate discontinuation of Sitagliptin + Metformin and prompt medical attention.
Prolonged use of Sitabetic M 50mg/500mg Tablets can indeed lead to vitamin B12 deficiency. This medication impairs the body's ability to absorb vitamin B12 in the gastrointestinal tract. Untreated deficiency can result in anemia and neurological complications, manifesting as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake is recommended by some experts at least annually.
Store this medication in its original, tightly sealed container, following all storage instructions provided on the packaging. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and other individuals.
Sitabetic M 50mg/500mg tablets contain sitagliptin and metformin, working together to manage type 2 diabetes in adults. This medication helps regulate blood sugar levels when combined with a healthy diet and exercise program. Metformin reduces glucose production by the liver and enhances insulin sensitivity. Sitagliptin's action involves DPP4 enzyme inhibition, leading to increased insulin secretion from the pancreas. This combination therapy is unsuitable for individuals under 18.
Sitabetic M 50mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, abdominal discomfort, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Individuals with hypersensitivity to any Sitabetic M 50mg/500mg Tablet constituent should not use this medication. Its use is contraindicated in patients experiencing severe renal or hepatic dysfunction, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabetic M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Indeed, Sitagliptin/Metformin 50mg/500mg tablets may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this uncommon adverse effect linked to metformin necessitates avoidance in individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Lactic acidosis symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitabetic M 50mg/500mg Tablet use can indeed lead to vitamin B12 deficiency. This medication disrupts the stomach's absorption of vitamin B12. Untreated deficiency may result in anemia and neurological issues, manifesting as tingling or numbness in the extremities, weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental vitamin B12 intake, at least annually, is recommended by some researchers.
Retain this medication within its original, securely sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Sitabetic M 50mg/500mg Ta...
163
MRP 189
13% off